PTN News

  • PTN to present findings at PAS 2015 February 19, 2015 Researchers will be presenting results from PTN studies at the annual meeting of the Pediatric Academic Societies, to be held April 25-28, 2015, in San Diego. Presenters will include: M. Smith et al., Pharmacokinetics of Multiple-Dose Intravenous Clindamycin in Obese Children (poster) J. Momper et al., Population Pharmacokinetics of Fluconazole in Extremely Low Birth Weight Infants (platform) J. ...
  • EnRICH Innovative Trial Design Course 2015: Coming in April February 5, 2015 From April 8-10 in Toronto, the Enhancing Research in International Child Health (EnRICH) group will offer a 3-day intermediate-level course in pediatric trial design. The course will cover a conceptual framework that includes outcome selection and measurement, value of information, cost effectiveness, risk of bias, and choice of comparators. Each day will include a mix ...
  • The PTN Post November 4, 2014 The PTN Post
  • PTN News October 31, 2014 PTN News
  • A POPS site goes above and beyond October 14, 2014 For an example of an outstanding PTN site, look no further than Ann & Robert H. Lurie Children’s Hospital of Chicago. The top enrolling site for the POPS study, Lurie Children’s has enrolled 244 patients as of September 22. To put this number into perspective, the second highest enrolling POPS site has recruited 117 patients, ...
  • The PTN pantoprazole study enrolls its first patient July 10, 2014 The PTN study of the effect of obesity on the pharmacokinetics of pantoprazole in children and adolescents has enrolled its first patient. The study team at Arkansas Children’s Hospital (PI Laura James, MD, SC Lee Howard, RN) did the honors. Obese children are more frequently diagnosed with gastroesophageal reflux disease (GERD) than children of normal weight. ...
  • SCAMP enrolls its first patient May 19, 2014 SCAMP—a randomized, multicenter, open-label Safety study of Clindamycin, Ampicillin, Metronidazole, and Piperacillin-tazobactam in infants with complicated intra-abdominal infections—enrolled its first patient over the weekend. The research team at the University of Florida–Jacksonville Shands Medical Center did the honors, led by site principal investigator Mark Hudak and study coordinator Renee Prince. SCAMP is seeking to determine the ...
  • EnRich Innovative Trial Design Course Being Offered at the Hospital for Sick Children in Toronto May 15, 2014 EnRICH Innovative Trial Design Course
  • SCAMP takes off March 14, 2014 SCAMP is taking off. A randomized, multicenter, open-label safety study of clindamycin, ampicillin, metronidazole, and piperacillin-tazobactam in infants with complicated intra-abdominal infections, SCAMP held its first investigator meeting on 2/28/2014. Twenty-five sites have been selected to date, with an additional 25 sites in the U.S. still to be recruited. To learn more about SCAMP, visit clinicaltrials.gov. ...
  • Methadone study enrolls first patient January 17, 2014 On January 10, 2014, the site team at the Medical University of South Carolina enrolled the first patient into the “Pharmacokinetics of Multiple-dose Methadone in Children” study. Andrew Atz, MD, principal investigator, Hibah Al Nasiri, study coordinator, and Patricia Infinger, research manager, oversee the team at this institution. This multicenter study will determine the pharmacokinetics of ...